http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-113402453-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07B2200-07 |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12P17-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D213-69 |
| classificationIPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-465 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D213-69 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P17-12 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4412 |
| filingDate | 2021-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2022-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2022-08-05-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-113402453-B |
| titleOfInvention | A kind of pyridone tetramycin and preparation method thereof and application in the preparation of anticancer drugs |
| abstract | The invention discloses a pyridone tetromycin, a preparation method and an application in the preparation of anticancer drugs. The pyridone tetromycin compound piericidin N of the present invention, whose structural formula is shown in formula (I), is an unreported new compound. The invention discloses that piericidin N has obvious selective inhibitory activity on human promyelocytic leukemia cells HL-60, and the pyridone pyreomycin can be used to prepare specific anti-leukemia drugs. Therefore, the present invention provides candidate compounds for the development of new anti-leukemia drugs, and is of great significance to the development of microbial drug resources in my country. |
| priorityDate | 2021-06-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 61.